CoreCap Advisors
DRUG icon

CoreCap Advisors’s Bright Minds Biosciences DRUG Stock Holding History

CoreCap Advisors’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$50 Buy
+1
New +$71 ﹤0.01% 3091

Other funds holding DRUG

RE
Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

CoreCap Advisors's DRUG Position: Q3 2026 in Review

CoreCap Advisors opened a new position in Bright Minds Biosciences (DRUG) in Q3 2026: 1 share worth $50. The stake represents ﹤0.01% of the portfolio and ranks #3091 among its holdings.

6 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.

  • CoreCap Advisors held 1 share of Bright Minds Biosciences worth $50 as of Q3 2026.
  • Bright Minds Biosciences was a new CoreCap Advisors position in Q3 2026.
  • Bright Minds Biosciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #3091 holding.
  • 6 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.